Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
暂无分享,去创建一个
Gilda Alves | D. Kalume | R. Zingali | V. Sandim | M. R. Soares | Vanessa Sandim | Denise de Abreu Pereira | Dário Eluan Kalume | Ana Lucia Oliveira-Carvalho | Antonio Augusto Ornellas | Marcia Regina Soares | Russolina Benedeta Zingali | G. Alves | D. A. Pereira | A. Ornellas | A. L. Oliveira-Carvalho
[1] W. Rathmell,et al. Renal cell carcinoma , 2007, Current opinion in oncology.
[2] S. Herrell,et al. Statin use is associated with improved survival in patients undergoing surgery for renal cell carcinoma. , 2015, Urologic oncology.
[3] O. Hashim,et al. Identification of O-glycosylated Proteins That Are Aberrantly Excreted in the Urine of Patients with Early Stage Ovarian Cancer , 2013, International journal of molecular sciences.
[4] O. Hashim,et al. Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin , 2010, Proteome Science.
[5] G. Yousef,et al. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry. , 2009, Journal of proteome research.
[6] E. Rech,et al. Detection and expression analysis of recombinant proteins in plant-derived complex mixtures using nanoUPLC-MS(E). , 2011, Journal of separation science.
[7] M. Mann,et al. In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.
[8] K. Pummer,et al. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients , 2013, British Journal of Cancer.
[9] Martin Norling,et al. Comprehensive human urine standards for comparability and standardization in clinical proteome analysis , 2010, Proteomics. Clinical applications.
[10] J. Goldblum,et al. Apolipoprotein D is down-regulated during malignant transformation of neurofibromas. , 2005, Human pathology.
[11] Stefano Ferrero,et al. Human urine biomarkers of renal cell carcinoma evaluated by ClinProt , 2008, Proteomics. Clinical applications.
[12] G. Mauri,et al. Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches , 2014, PloS one.
[13] G. Candiano,et al. From hundreds to thousands: Widening the normal human Urinome , 2014, Data in brief.
[14] V. Sandim,et al. Renal Cell Carcinoma and Proteomics , 2010, Urologia Internationalis.
[15] Hersh Chandarana,et al. Contemporary imaging of the renal mass. , 2012, The Urologic clinics of North America.
[16] G. Domont,et al. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues. , 2013, International braz j urol : official journal of the Brazilian Society of Urology.
[17] Yi-ding Chen,et al. Urinary proteomics as a novel tool for biomarker discovery in kidney diseases , 2010, Journal of Zhejiang University SCIENCE B.
[18] J. Patard,et al. Renal cell carcinoma guideline. , 2007, European urology.
[19] Rembert Pieper,et al. Characterization of the human urinary proteome: A method for high‐resolution display of urinary proteins on two‐dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots , 2004, Proteomics.
[20] Ming Li,et al. PEAKS: powerful software for peptide de novo sequencing by tandem mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[21] A. Borowsky,et al. Grade-dependent Proteomics Characterization of Kidney Cancer*S , 2009, Molecular & Cellular Proteomics.
[22] M. Mann,et al. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. , 2011, Journal of proteome research.
[23] Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC). , 2013, International braz j urol : official journal of the Brazilian Society of Urology.
[24] Chun-Liang Tung,et al. Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma. , 2013, Journal of pharmaceutical and biomedical analysis.
[25] Danny C. Kim,et al. Contemporary Imaging of the Renal Mass , 2011, Current urology reports.
[26] A. Pantuck,et al. Molecular biology of renal cortical tumors. , 2008, The Urologic clinics of North America.
[27] W. Davidson,et al. Apolipoprotein A-I mimetics and high-density lipoprotein function , 2012, Current opinion in endocrinology, diabetes, and obesity.
[28] M. Silva-Neto,et al. Four conventional soybean [Glycine max (L.) Merrill] seeds exhibit different protein profiles as revealed by proteomic analysis. , 2014, Journal of agricultural and food chemistry.
[29] Giuseppe Di Lorenzo,et al. Re: Börje Ljungberg, Damian C. Hanbury, Marcus A. Kuczyk, Axel S. Merseburger, Peter F.A. Mulders, Jean-Jaques Patard and Ioanel C. Sinescu. Renal Cell Cacinoma Guideline. Eur Urol 2007;51:1502–10 , 2007 .
[30] V. Thongboonkerd,et al. Systematic evaluation of sample preparation methods for gel-based human urinary proteomics: quantity, quality, and variability. , 2006, Journal of proteome research.
[31] P. Rudd,et al. Acute phase glycoproteins: bystanders or participants in carcinogenesis? , 2012, Annals of the New York Academy of Sciences.